CG Oncology (CGON) Net Margin (2023 - 2026)
CG Oncology (CGON) posted Net Margin of 40904.25% for Q1 2026, down 2190.82% on a QoQ basis from 1785.57% in Q4 2025, and up 19326498.0% year-over-year from N/an in Q1 2025.
CG Oncology (CGON) Net Margin (2023 - 2026) Analysis & Trends
CG Oncology's Net Margin history runs 4 years deep, the most recent figure standing at 40904.25% for Q1 2026.
- Quarterly Net Margin rose 19326498.0% year-over-year to 40904.25% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17098.46% (up 1203643.0% YoY) and the FY2025 annual result came in at 3985.02%, up 374447.0% from the prior year.
- Net Margin was 40904.25% for Q1 2026 at CG Oncology, down from 1785.57% in the prior quarter.
- Across five years, Net Margin topped out at 1785.57% in Q4 2025 and bottomed at 2249000.0% in Q4 2023.
- A 4-year average of 255961.76% and a median of 17028.83% in 2024 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2024 — Net Margin surged 224202675 bps — and 2025, when it plunged 23096847 bps.
- CG Oncology's Net Margin stood at 2249000.0% in 2023, then jumped by 100 bps to 6973.25% in 2024, then surged by 74 bps to 1785.57% in 2025, then slumped by 2191 bps to 40904.25% in 2026.
- Business Quant data shows CGON's Net Margin at 40904.25% in Q1 2026, 1785.57% in Q4 2025, and 14071.67% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CG Oncology | 6.01 Bn | 6.01 Bn | -1.88 Mn | -40,904.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40,904.25% |
| Dec 31, 2025 | -1,785.57% |
| Sep 30, 2025 | -14,071.67% |
| Mar 31, 2025 | -234,169.23% |
| Dec 31, 2024 | -6,973.25% |
| Sep 30, 2024 | -47,453.49% |
| Jun 30, 2024 | -17,028.83% |
| Mar 31, 2024 | -3,200.76% |
| Dec 31, 2023 | -2,249,000.00% |
| Sep 30, 2023 | -194,600.00% |
| Mar 31, 2023 | -6,392.27% |